نتایج جستجو برای: tpa therapy

تعداد نتایج: 659243  

Journal: :AJNR. American journal of neuroradiology 2010
D-S Yoo Y-D Won P-W Huh H-E Shin K-T Kim S-G Kang S-B Lee K-S Cho

BACKGROUND AND PURPOSE IV administration of tPA is accepted as a standard treatment for acute cerebral ischemia, but the clinical outcomes cannot be guaranteed in patients who are not recanalized after IV-tPA and in those who are not eligible for IV-tPA. In this study, outcomes from groups of patients treated with additional IA thrombolytic therapy with the use or omission of IV-tPA administrat...

Journal: :Japanese circulation journal 1998
N Ogata H Ogawa Y Ogata Y Numata Y Morigami H Suefuji H Soejima T Sakamoto H Yasue

The fibrinolytic capacity of patients with acute myocardial infarction (AMI) is known to be impaired. The primary regulatory element of the fibrinolytic system is plasminogen activator inhibitor (PAI). It has been previously observed that there are 2 peaks in the plasma PAI level of AMI patients at 4h and 16h after thrombolytic therapy with recombinant tissue plasminogen activator (rtPA). Lanot...

2017
Fahad S. Al-Ajlan Emmad Qazi Chi Kyung Kim E. Prasanna Venkatesan Lexi Wilson Bijoy K. Menon

Acute ischemic stroke (AIS) is a common neurovascular emergency causing significant burden to society. Currently the main focus of AIS treatment is to restore blood flow to at risk brain tissue. For the last twenty years, intravenous tissue plasminogen activator (tPA) was the only proven therapy for patients with AIS. More recently, five randomized clinical trials established the efficacy of en...

پایان نامه :وزارت علوم، تحقیقات و فناوری - دانشگاه سمنان - دانشکده علوم تربیتی و روانشناسی 1391

anxiety is one common disorder during childhood. in curing anxiety disorders, there are different types of psychological remedies, pharmotherapy, family therapy, and music therapy that can improve the individual’s anxiety, but we need some other remedies to improve social and emotional relationship and interactions. considering the importance of curing the anxiety disorders, the effect of sand ...

Journal: :Stroke 2014
Emanuela Keller Kyra J Becker

O f the many publications in this field, the ones discussed hereunder seem to be most relevant for clinical practice. Intravenous thrombolysis with tissue plasminogen activa-tor (tPA) is the only therapy proven to improve outcome in ischemic stroke. Studies of intravenous thrombolysis show that response to therapy is time-dependent; the sooner the patients receive tPA, the better the chance of ...

2014
Yu-Yo Sun Yury M. Morozov Dianer Yang Yikun Li R. Scott Dunn Pasko Rakic Pak H. Chan Koji Abe Diana M. Lindquist Chia-Yi Kuan

Edaravone, a potent antioxidant, may improve thrombolytic therapy because it benefits ischemic stroke patients on its own and mitigates adverse effects of tissue plasminogen activator (tPA) in preclinical models. However, whether the combined tPA-edaravone therapy is more effective in reducing infarct size than singular treatment is uncertain. Here we investigated this issue using a transient h...

Journal: :Stroke 2003
Peter U Heuschmann Klaus Berger Bjoern Misselwitz Peter Hermanek Carsten Leffmann Michael Adelmann Hans-Joachim Buecker-Nott Joachim Rother Bernhard Neundoerfer Peter L Kolominsky-Rabas

BACKGROUND AND PURPOSE There is little information about early outcome after intravenous application of tissue-type plasminogen activator (tPA) for stroke patients treated in community-based settings. We investigated the association between tPA therapy and in-hospital mortality in a pooled analysis of German stroke registers. METHODS Ischemic stroke patients admitted to hospitals cooperating ...

Journal: :Stroke 2001
C M McPherson D Woo P L Cohen A M Pancioli B M Kissela J A Carrozzella T A Tomsick M Zuccarello

BACKGROUND AND PURPOSE Tissue plasminogen activator (tPA) has been shown to be effective for acute ischemic stroke. However, if a high-grade cervical carotid stenosis remains despite tPA therapy, patients are at risk for recurrent stroke. Carotid endarterectomy (CEA) has been shown to be effective in symptomatic patients with high-grade cervical carotid stenosis in reducing the risk of stroke, ...

Journal: :Stroke 2010
Longfei Jia Michael Chopp Li Zhang Mei Lu Zhenggang Zhang

BACKGROUND AND PURPOSE Erythropoietin (EPO), a hematopoietic cytokine, exerts neuroprotective effects in experimental stroke. In the present study, we investigated the effect of recombinant human EPO (rhEPO) in combination with tissue plasminogen activator (tPA) on embolic stroke. METHODS Rats subjected to embolic middle cerebral artery occlusion (MCAO) were treated with rhEPO (5000 U/kg) in ...

Journal: :Journal of neurointerventional surgery 2015
Mahesh V Jayaraman M Shazam Hussain Todd Abruzzo Barbara Albani Felipe C Albuquerque Michael J Alexander Sameer A Ansari Adam S Arthur Blaise Baxter Ketan R Bulsara Michael Chen Josser E Delgado Almandoz Justin F Fraser Don V Heck Steven W Hetts Michael Kelly Seon-Kyu Lee Thabele Leslie-Mawzi Ryan A McTaggart Philip M Meyers Charles Prestigiacomo G Lee Pride Athos Patsalides Robert M Starke Robert W Tarr Don Frei Peter Rasmussen

In 2013, there were three major trials that were published comparing outcomes of treatment of acute ischemic stroke with IV tPA to interventional methods: IMS III, MR RESCUE, and SYNTHESIS. These trials concurrently failed to show the superiority of endovascular therapy compared to IV tPA for the treatment of acute ischemic stroke. There has been much discussion following the publication of the...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید